Abstract
Previously, we demonstrated a significant correlation between post-IAPBI TGF-β1 levels and occurrence of moderate-to-severe RIF as measured by tissue compliance meter (TCM). We now examine earlier time points at which TGF-β1 values in women treated with IAPBI are best predictive of developing RIF.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
